Literature DB >> 7361797

Effect of ascorbic acid on urine pH in patients with injured spinal cords.

S K Hetey, M L Kleinberg, W D Parker, E W Johnson.   

Abstract

The ability of ascorbic acid to lower urinary pH in patients with spinal cord injury and neurogenic bladder was studied. Ascorbic acid (1 g four times daily) or placebo was administered for five days in a double-blind, crossover study to 20 patients with spinal cord injury and neurogenic bladder. Urine pH was measured for two days before and during administration of placebo or ascorbic acid. The mean decrease in urinary pH with ascorbic acid was 0.58, but this reduction was not statistically or clinically significant. Only 7 of 20 patients showed a mean urine pH of 5.5 or less (acidic) during treatment with ascorbic acid. The study suggests that an ascorbic acid dosage of 1 g four times daily should not be used to maintain an acidic urinary pH for control of urinary tract infections in patients with spinal cord injuries.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7361797

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  4 in total

Review 1.  Catheter-associated infections: pathogenesis affects prevention.

Authors:  Barbara W Trautner; Rabih O Darouiche
Journal:  Arch Intern Med       Date:  2004-04-26

2.  Is it safe to prescribe ascorbic acid for urinary acidification in stone-forming patients with alkaline urine?

Authors:  Yasser A Noureldin; Alexandrine da Silva; Nader Fahmy; Sero Andonian
Journal:  Turk J Urol       Date:  2017-04-18

Review 3.  Methenamine hippurate for preventing urinary tract infections.

Authors:  Bon San B Lee; Tushar Bhuta; Judy M Simpson; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

4.  Vitamin C inhibits crystallization of struvite from artificial urine in the presence of Pseudomonas aeruginosa.

Authors:  Muhammed A P Manzoor; Surya Ram Duwal; M Mujeeburahiman; Punchappady-Devasya Rekha
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.